Nachrichten zur Genflow Biosciences PLC Aktie

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) told investors it has completed the dosing phase of its canine gene therapy trial. All enrolled dogs...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the companys recent milestone – the granting…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) told investors it has filed a patent examination request in China for its SIRT6 gene variants…

Shares in Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) jumped 19% on Friday, extending a remarkable 169% gain over the week, after…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the London-listed longevity company, has reached a key milestone in its effort to see whether…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) shares jumped 88% on Thursday after the longevity-focused biotech firm announced a £440,000 fundraising that...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the longevity-focused biotech group, has secured £340,000 in fresh funding through the issue of 40…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has said it expects 2026 to be a decisive year as it pushes forward its…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s recently signed confidential disclosure...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has moved to strengthen its intellectual property in Asia by filing for examination of a…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has reported progress across its two main research programmes, as the company moves closer to…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) confirmed that it has been awarded roughly €4 million in non-dilutive financial support from the Wallonia...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has made headway across its gene therapy pipeline, reporting strong mid-year momentum in its programmes...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has signed a long-term agreement with its Belgian research partner CER Groupe to support the…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has taken a step forward in its bid to protect a key gene therapy technology…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has topped up its coffers with a £500,000 share subscription to support its proof-of-concept trial.…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) outlined recent developments across its pipeline following the release of its 2024 results. The company…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) reported progress across its research programmes and raised new funds during the 2024 financial year.…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about the company’s new strategic partnership with US-based…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), a London-listed biotech focused on longevity, has signed a partnership deal with US artificial intelligence...…

Shares in longevity-focused Genflow Biosciences jumped on Monday after the company outlined plans to to accelerate drug discovery through the…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has launched a new programme aimed at developing gene therapies for eye conditions, expanding the…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) CEO Dr Eric Leire talked with Proactive about a pivotal new direction for the company…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), the only longevity-focused biotech listed in Europe, has secured a £434,083 equity investment from a…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF)CEO Dr Eric Leire talked with Proactive about the company’s significant progress toward securing European...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) shares were up as much as 8% in morning trading after the company announced it had…

Genflow Biosciences Plc, the London-listed biotechnology company, has achieved a significant milestone in its pursuit of longevity research patents. Genflow…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has moved a step closer to securing a European patent for its SIRT6 variant, a potential…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has hailed 2024 as a transformational year, highlighting progress in its mission to develop therapies…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), a company specialising in longevity research and therapies for age-related diseases, has secured over €4...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) announced significant progress in its primary longevity programmes and bolstered its financial position...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), a leader in longevity research, has announced significant advancements in its pre-clinical efforts aimed at...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has received €395,847, representing 50% of the Exofastrack research grant from the Government of Wallonia....…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has received €381,434 from a research grant provided by the Government of Wallonia in Belgium.…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), which is focused on longevity and age-related diseases, has successfully raised £715,000 through a...…

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has confirmed a key patent has been published that could pave the way for treatments in age-related…